Nancy Boeckx

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 449 citations · Full text

Medicine, Hematology, Oncology +16

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

Carlos Graux, Jan Cools, Cindy Melotte et al. · Nature Genetics · 2004 · 422 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +11

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

Jacqueline Cloos, Bianca F. Goemans, Corine J. Hess et al. · Leukemia · 2006 · 178 citations

Medicine, Molecular Genetics, Oncology +14

Quality assessment program for<scp>E</scp>uro<scp>F</scp>low protocols: Summary results of four‐year (2010–2013) quality assurance rounds

Tomáš Kalina, Juan Flores‐Montero, Quentin Lécrevisse et al. · Cytometry Part A · 2014 · 137 citations · Full text

Medicine, Hematology, Oncology +14

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg®) treatment in acute myeloid leukemia patients

Vincent H. J. van der Velden, Nancy Boeckx, Inge Jedema et al. · Leukemia · 2004 · 115 citations · Full text

Medicine, Hematology, Oncology +13